EUVIMEDEUVIMED entdecken
Crossref

Nanoassembly with self-regulated magnetic thermal therapy and controlled immuno-modulating agent release for improved immune response

Maoyu Gao, Kai Feng, Xinmiao Zhang, Yiling Ruan, Guizhen Zhao, Huihui Liu, Xiaolian Sun

Journal of Controlled Release · 2023

DOI: 10.1016/j.jconrel.2023.03.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Maoyu Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutics, China Pharmaceu…. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy is an emerging cancer therapeutic method by activating the patient's immune system but suffers from low immunogenicity at tumor sites. Fever-like heat is known to modulate an immune-friendly tumor microenvironment. Here, temperature-responsive iron oxide nanoassemblies (IONAs) are developed by crosslinking iron oxide nanoparticles (IONPs) and loaded with JQ1 (JQ1/IONAs), an immuno-modulating agent known to down-regulate PD-L1. In the presence of an alternating magnetic field (AMF), the IONAs demonstrate a much more effective magnetic thermal effect than IONPs and are responsively disassembled to prevent overheating. Compared with IONPs + AMF (∼ 41 °C) and unresponsive nanoassemblies (uIONAs) + AMF (∼ 50 °C), the IONAs + AMF with a temperature heated around 45 °C show a much better immune response and anti-tumor effect. Further combining the mild thermal therapy with controlled release of JQ1, the JQ1/IONAs + AMF completely eradicate the primary tumors and trigger a strong immune effect to inhibit the distant tumor growth as well as prevent tumor recurrence and metastasis. Our JQ1/IONAs not only provide a magnetic thermal agent with effective heating and temperature self-regulation ability but also serve as a heat-triggered JQ1 carrier to spontaneously combine mild magnetic thermal therapy with immune checkpoint blockade therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperthermia, InducedNeoplasmsHumansHot TemperatureMagnetic FieldsCell Line, TumorTumor MicroenvironmentFerric Compounds

Stichwörter der Autor:innen

Immune checkpoint blockadeMagnetic field triggered drug releaseMild magnetic thermal therapyResponsive assembliesStrong immune response

Substanzen

ferric oxideFerric Compounds

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
  • State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China. Electronic address: xiaolian_…

Zitieren

APA

Gao, M., Feng, K., Zhang, X., Ruan, Y., Zhao, G., Liu, H., & Sun, X. (2023). Nanoassembly with self-regulated magnetic thermal therapy and controlled immuno-modulating agent release for improved immune response. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.03.035

Vancouver

Gao M, Feng K, Zhang X, Ruan Y, Zhao G, Liu H, et al. Nanoassembly with self-regulated magnetic thermal therapy and controlled immuno-modulating agent release for improved immune response. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.03.035

BibTeX
@article{Gao2023,
  author = {Gao, Maoyu and Feng, Kai and Zhang, Xinmiao and Ruan, Yiling and Zhao, Guizhen and Liu, Huihui and Sun, Xiaolian},
  title = {Nanoassembly with self-regulated magnetic thermal therapy and controlled immuno-modulating agent release for improved immune response},
  journal = {Journal of Controlled Release},
  year = {2023},
  doi = {10.1016/j.jconrel.2023.03.035}
}
Kostenlos starten →